- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- HonorHealth Research Institute - Bisgrove Scottsdale, Arizona, United States
- University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Washington University School of Medicine St Louis, Missouri, United States
Clinical trial condition
Melanoma
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
2,209 public trials
376 recruiting studies
Melanoma trial results
NCT02129075
- Conditions
- Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +25 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
- Mount Sinai Hospital New York, United States
- Duke University Medical Center Durham, North Carolina, United States
NCT03652077
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +96 more
- Locations
-
- The Angeles Clinical and Research Institute Los Angeles, California, United States
- University of Mississippi Jackson, Mississippi, United States
- Hackensack Medical Center Hackensack, New Jersey, United States
- Carolina BioOncology Huntsville, North Carolina, United States
NCT03508297
- Conditions
- Hutchinson's Melanotic Freckle, Lentigo Maligna, Melanoma, +12 more
- Locations
-
- Skin Care Network Barnet Ltd London, United Kingdom
NCT02983006
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Laura and Isaac Perlmutter Cancer Center New York, United States
NCT03409419
- Conditions
- Disease Attributes, Malignant Melanoma, Melanoma, +14 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- City of Hope Duarte, California, United States
- Angeles Clinic and Research Institute Los Angeles, California, United States
- UCLA Medical Hematology and Oncology Los Angeles, California, United States
- Stanford University Palo Alto, California, United States
Completed
Biomarker-driven Therapy for Melanoma
NCT05063058
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
Not specified
NCT02173171
- Conditions
- Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Melanoma, Neoplasms, +10 more
- Locations
-
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- St Joseph Heritage Healthcare Santa Rosa, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
Completed
Advanced Melanoma in Russian Experience
NCT03663647
- Conditions
- BRAF V600 Mutation, Cutaneous Melanoma, Stage IV, Melanoma, +11 more
- Locations
-
- Moscow Regional Oncologic Dispensary Balashikha, Russia
- Belgorod Oncologic Dispensary Belgorod, Russia
- Republican Clinical Oncologic Dispensary Cheboksary, Russia
- Kaluga Regional Clinical Oncologic Dispensary Kaluga, Russia